Press release, 3 September 2025
Minus 80° Celsius: Movianto has developed European solution for logistics in the ultra-deep-freeze sector
– Demand for international storage and distribution concepts in the pharmaceutical and healthcare industry is increasing
– Ultra-low temperature storage is required for some vaccines, research materials, raw materials or semi-finished products, as well as the increasing number of biotechnologically manufactured products
– Know-how multiplied: proven hardware and processes transferred to a total of nine European countries, with two more countries to follow
(Oss/Netherlands) Movianto, a logistics service provider specialising in the pharmaceutical and healthcare industries, has established a European network for ultra-low temperature storage at down to minus 80° Celsius. ‘We have scaled our expertise and capacity in this area, so that we now have ultra-low temperature freezers in nine European countries,’ says Thomas Creuzberger, CEO of Movianto, which belongs to the French Walden Group. ‘In two countries, namely Switzerland and Slovakia, we are still in the implementation phase. Otherwise, we can meet the growing demand of the pharmaceutical industry in this area at our own logistics sites in the United Kingdom, Belgium and the Netherlands, Denmark, France, Germany, Italy, Spain and the Czech Republic.’ Transport services for the products are also offered. The goods can either be transported in special containers, whereby the ultra-low temperature is kept constant, or the goods are thawed in a controlled manner during dispatch preparation and then transported to their destination with active cooling, either frozen (minus 20°C) or chilled at 2 to 8 degrees Celsius.
Movianto began to build up storage capacity in the ultra-low temperature sector and to develop shipping processes more than 10 years ago. During the coronavirus pandemic, the capacity has been further developed. For example, national solutions for the central storage and nationwide distribution of coronavirus vaccines were implemented in the Netherlands and the United Kingdom. ‘It’s not just a matter of getting the right special freezers, but above all of validating the equipment and securing all the associated processes,’ says Creuzberger. ‘We analysed the proven solutions, which were initially developed independently of each other, and then created a best practice model from them. This has now been transferred to all our national subsidiaries so that we are prepared for the increasing demand.’ Although the quantities of goods which need deep freezing are relatively small, they are of high value and need sensitive care. In addition to national tenders, there are an increasing number of tenders requesting capacities in various European countries. Creuzberger points to the growing number of biotechnologically manufactured products with special deep-freezing requirements. ‘But this temperature range is also becoming increasingly important in vaccine development. This is because, especially in the case of new vaccines, in early development phases insufficient stability data is available for different temperature ranges; this can only be obtained over time. And until then, in order to ensure 100 percent effectiveness, they are stored in ultra-low temperature freezers.’
About Movianto
Since 2020, Movianto is a part of the Walden Group. With its one-stop-shop service for the distribution of healthcare products, Walden is today Europe’s market leader for logistics and transport in the pharmaceutical and healthcare industry. Movianto strives to be the preferred European logistics partner for this industry and to provide the best service for pharmaceutical and biotech products, medical devices, and diagnostics. As an outsourcing partner along the logistics chain for such products, Movianto offers temperature-controlled warehouse logistics and transport, as well as complete solutions such as order to cash or purchasing and procurement services. Movianto’s international customers benefit from a Europe-wide network, a broad range of pharmaceutical logistics services, unique industry expertise, and standardised processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,700 people, has over 600,000 pallet spaces in its network of 23 own logistics centres in eleven European countries and operates throughout Europe. www.movianto.com
About Walden
Founded in 1951, the Walden Group is a French family business and European market leader for supply chain solutions in the healthcare sector. It focuses on two areas of expertise: logistics and transport of healthcare products (with Movianto for logistics, Eurotranspharma for last-mile temperature-controlled transport and Transpharma International for first-mile transport) and express transport (with Ciblex, DPXS, Eco course Optic and Relais Colis). To support these activities, the subsidiary Walden IT Solutions develops tailored to the specific needs of the Group’s customers.
The Group is present in 15 countries (France, Spain, Germany, Italy, the Netherlands, Belgium, Denmark, the UK, Ireland, Switzerland, Morocco, Poland, the Czech Republic, Slovakia and India). It achieved a turnover of 2.9 billion euros in 2023, employs more than 6,000 people at over 250 sites and manages almost one million square metres of warehouse space.
www.walden-group.com
Photos (free for editorial use):
Risk of frostbite: Protective clothing must be worn when removing products from ultra-low temperature freezers.
Contact for press enquiries:
Laure Murat (she/her) Ludwig-Michael Cremer (he/him)
Movianto Communication external press office Movianto
Tel +33 7 60 94 88 01 Tel +49 173 2 31 51 91
laure.murat@walden-group.com team@log-pr.de
We look forward to receiving digital or physical specimen copies!
If you do not wish to receive any further press releases from Movianto, please send a short e-mail to team@log-pr.de. Thank you!